Cryo-Cell Intl Inc (CCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 02-2023 | 11-2022 | 08-2022 | 05-2022 | 02-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 767 | 2,771 | 1,934 | 1,467 | 832 |
| Depreciation Amortization | 455 | 1,825 | 1,372 | 924 | 479 |
| Income taxes - deferred | N/A | -1,732 | N/A | N/A | N/A |
| Accounts receivable | -665 | -1,720 | -728 | -297 | -63 |
| Accounts payable and accrued liabilities | 222 | 116 | 303 | 233 | 358 |
| Other Working Capital | 83 | 4,250 | 1,657 | 639 | 107 |
| Other Operating Activity | 783 | 3,063 | 1,605 | 488 | -207 |
| Operating Cash Flow | $1,644 | $8,573 | $6,143 | $3,454 | $1,507 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -376 | -10,299 | -12,194 | -955 | -648 |
| Purchase Of Investment | -1,018 | -1,142 | -1,142 | -1,142 | -406 |
| Sale Of Investment | 191 | 1,161 | 1,141 | 1,128 | N/A |
| Purchase Sale Intangibles | N/A | -5,000 | -5,000 | -5,000 | -5,000 |
| Other Investing Activity | 0 | -5,000 | -5,000 | -5,000 | -5,000 |
| Investing Cash Flow | $-1,202 | $-15,280 | $-17,195 | $-5,969 | $-6,053 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 16,633 | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | 8,960 | N/A | N/A |
| Debt Repayment | -30 | -1,947 | -1,908 | -1,550 | -775 |
| Common Stock Issued | N/A | 551 | 551 | 32 | 32 |
| Common Stock Repurchased | -243 | -1,820 | -1,692 | -1,426 | -829 |
| Dividend Paid | N/A | -7,673 | N/A | N/A | N/A |
| Other Financing Activity | -500 | -5,597 | -197 | 0 | 0 |
| Financing Cash Flow | $-773 | $148 | $5,714 | $-2,944 | $-1,572 |
| Beginning Cash Position | 1,704 | 8,263 | 8,263 | 8,263 | 8,263 |
| End Cash Position | 1,373 | 1,704 | 2,925 | 2,805 | 2,145 |
| Net Cash Flow | $-331 | $-6,559 | $-5,338 | $-5,459 | $-6,119 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,644 | 8,573 | 6,143 | 3,454 | 1,507 |
| Capital Expenditure | -376 | -12,169 | -12,194 | -955 | -648 |
| Free Cash Flow | 1,268 | -3,596 | -6,051 | 2,499 | 859 |